Clicky

Avita Medical Limited(RCEL)

Description: Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients 18 years and older. The company has a preclinical research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa. The company is based in Valencia, California.


Keywords: Medicine Clinical Medicine Rare Diseases Regenerative Medicine Clinical Research Dermatology Skin Wound Aesthetics Burns Platform Technology Suspension Treatment Solutions Chronic Wounds Chronic Wound Genodermatoses Epidermolysis Bullosa Regenerative Products Avita Medical Spray On Skin Trauma Injuries University Of Colorado School University Of Colorado School Of Medicine

Home Page: www.avitamedical.com

RCEL Technical Analysis

28159 Avenue Stanford
Valencia, CA 91355
United States
Phone: 661 367 9170


Officers

Name Title
Mr. James M. Corbett CEO, Pres & Exec. Director
Mr. Michael Bria Holder MBA Chief Financial Officer
Ms. Kathy M. McGee Chief Operating Officer
Mr. Andrew Quick Chief Technology Officer
Ms. Donna Shiroma Gen. Counsel & Sec.
Ms. Erin Liberto Chief Commercial Officer
Mr. David Fencil VP of Global Operations
Ms. Debbie Garner VP of Global Marketing

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

GIC Sector: Health Care
GIC Group: Pharmaceuticals, Biotechnology & Life Sciences
GIC Industry: Biotechnology
GIC Sub-Industry:
Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 2.0995
Price-to-Sales TTM: 6.634
IPO Date: 2019-10-01
Fiscal Year End: June
Full Time Employees: 116
Back to stocks